1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Sepsis Diagnostics Market – By Product

1.3.2        North America Sepsis Diagnostics Market – By Technology

1.3.3        North America Sepsis Diagnostics Market – By Method

1.3.4        North America Sepsis Diagnostics Market – By Test Type

1.3.5        North America Sepsis Diagnostics Market – By Pathogen

1.3.6        North America Sepsis Diagnostics Market – By End User

1.3.7        North America Sepsis Diagnostics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Sepsis Diagnostics Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America Sepsis Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        High Incidence of Sepsis due to Increasing Nosocomial Infections

5.1.2        Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches

5.2         Market Restraints

5.2.1        Lack of Skilled Professionals

5.3         Market Opportunities

5.3.1        Increase in Funding and Support for Sepsis Diagnostics Research

5.4         Future Trends

5.4.1        Rising Technological Advancements in Sepsis Diagnosis

5.5         Impact Analysis

6.           Sepsis Diagnostics Market– North America Analysis

6.1         North America Sepsis Diagnostics Market Revenue Forecast and Analysis

7.           North America Sepsis Diagnostics Market Revenue and Forecasts To 2028– by Product

7.1         Overview

7.2         North America Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)

7.3         Instruments

7.3.1        Overview

7.3.2        Instruments: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4         Reagents and Assays

7.4.1        Overview

7.4.2        Reagents and Assays: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.5         Blood Culture Media

7.5.1        Overview

7.5.2        Blood Culture Media: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.6         Software

7.6.1        Overview

7.6.2        Software: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8.           North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Technology

8.1         Overview

8.2         North America Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)

8.3         Molecular Diagnostics

8.3.1        Overview

8.3.2        Molecular Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.1          Polymerase Chain Reaction

8.3.2.1.1          Overview

8.3.2.1.2          Polymerase Chain Reaction: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.2          Peptide Nucleic Acid-Fluorescent in Situ Hybridization

8.3.2.2.1          Overview

8.3.2.2.2          Peptide Nucleic Acid-Fluorescent in Situ Hybridization: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.3          Syndromic Panel-Based Testing

8.3.2.3.1          Overview

8.3.2.3.2          Syndromic Panel-Based Testing: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.2.4          Microarrays

8.3.2.4.1          Overview

8.3.2.4.2          Microarrays: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         Flow Cytometry

8.4.1        Overview

8.4.2        Flow Cytometry: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.3        Real-Time Cell Analysis

8.4.3.1          TaqMan-Based Multiplex RT PCR and Blood Culture

8.4.3.1.1          Characteristics of TaqMan Assays

8.4.3.2          Magicplex (TM)Sepsis Real-Time Tests Performed in Tertiary Regina Margherita Children's Hospital (Turin, Italy) – Case Study

8.4.3.2.1          Abstract

8.4.3.2.2          Conclusion:

8.4.3.3          Companies that are engaged in providing Sepsis Diagnostic solutions

8.4.3.4          Sepsis diagnosis by real-time PCR

8.4.3.5          New next-generation sequencing technique and technological advancements/innovations

8.4.3.6          Real Time Cellular Analysis Using Impedance Measurements

8.4.4        Real-Time Cell Analysis: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5         Microfluidics

8.5.1        Overview

8.5.2        Microfluidics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.6         Immunoassay

8.6.1        Overview

8.6.2        Immunoassay: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7         Biomarkers

8.7.1        Overview

8.7.2        Biomarkers: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.7.3        Metabolomics

8.7.3.1          Metabolite Profile in Sepsis

8.7.3.2          Penetration/Usage Pattern of Metabolomics in Sepsis Diagnosis

8.7.3.3          Early Prediction of Sepsis by Metabolite Profiling

8.7.3.4          Future Role of Omics in Diagnosis and Therapy of Sepsis

8.7.3.4.1          Genomics

8.7.3.4.2          Proteomics

8.7.3.5          Sepsis Biomarkers and Diagnostic Tools

8.7.3.6          Role Metabolomics and Proteomics in Sepsis

8.7.3.7          Potential Approach for Identifying Small Molecule Biomarkers for Acute Kidney Disease Prognosis

8.7.3.8          Recent Application of Metabolomics in Sepsis Diagnosis

8.7.3.9          Metabolics in Mitochondrial Function

8.7.3.10       Substantial Potential of Metabolomics in Diagnostics for Mitochondrial Medicine

8.7.4        Metabolomics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.8         Microbiology

8.8.1        Overview

8.8.2        Microbiology: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Method

9.1         Overview

9.2         North America Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

9.3         Automated Diagnostics

9.3.1        Overview

9.3.2        Automated Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Conventional Diagnostics

9.4.1        Overview

9.4.2        Conventional Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Test Type

10.1      Overview

10.2      North America Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

10.3      Point-of-Care Tests

10.3.1     Overview

10.3.2     Point-of-Care Tests: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.4      Laboratory Tests

10.4.1     Overview

10.4.2     Laboratory Tests: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.        North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 – Pathogen

11.1      Overview

11.2      North America Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

11.3      Bacterial Sepsis

11.3.1     Overview

11.3.2     Bacterial Sepsis: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.4      Fungal Sepsis

11.4.1     Overview

11.4.2     Fungal Sepsis: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

11.5      Others

11.5.1     Overview

11.5.2     Others: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.        North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 – End User

12.1      Overview

12.2      North America Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

12.3      Hospitals

12.3.1     Overview

12.3.2     Hospitals: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.4      Pathology and Reference Laboratories

12.4.1     Overview

12.4.2     Pathology and Reference Laboratories: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

12.5      Others

12.5.1     Overview

12.5.2     Others: North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

13.        North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 – Country Analysis

13.1      Overview

13.1.1     North America: North America Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

13.1.1.1       US: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.1.1.1       Overview

13.1.1.1.2       US: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.1.1.3       US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

13.1.1.1.4       US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.1.1.1.4.1    Biomarkers: Metabolomics 2019-2028

13.1.1.1.4.2    Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.1.4.3    US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.1.1.1.5       US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.1.1.1.6       US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.1.1.1.7       US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.1.1.1.8       US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

13.1.1.2       Canada: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.1.2.1       Overview

13.1.1.2.2       Canada: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.1.2.3       Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

13.1.1.2.4       Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.1.1.2.4.1    Biomarkers: Metabolomics 2019-2028

13.1.1.2.4.2    Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.2.4.3    Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.1.1.2.5       Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.1.1.2.6       Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.1.1.2.7       Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.1.1.2.8       Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

13.1.1.3       Mexico: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.1.3.1       Overview

13.1.1.3.2       Mexico: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.1.3.3       Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

13.1.1.3.4       Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

13.1.1.3.4.1    Biomarkers: Metabolomics 2019-2028

13.1.1.3.4.2    Flow Cytometry: Real-Time Cell Analysis 2019-2028

13.1.1.3.4.3    Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

13.1.1.3.5       Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

13.1.1.3.6       Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

13.1.1.3.7       Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

13.1.1.3.8       Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)

14.        North America Sepsis Diagnostics Market–Industry Landscape

14.1      Overview

14.2      Growth Strategies in the Sepsis Diagnostics Market (%)

14.3      Organic Developments

14.3.1     Overview

14.4      Inorganic Developments

14.4.1     Overview

15.        Company Profiles

15.1      Abbott

15.1.1     Key Facts

15.1.2     Business Description

15.1.3     Products and Services

15.1.4     Financial Overview

15.1.5     SWOT Analysis

15.1.6     Key Developments

15.2      F. HOFFMANN-LA ROCHE LTD.

15.2.1     Key Facts

15.2.2     Business Description

15.2.3     Products and Services

15.2.4     Financial Overview

15.2.5     SWOT Analysis

15.2.6     Key Developments

15.3      Immunexpress Inc.

15.3.1     Key Facts

15.3.2     Business Description

15.3.3     Products and Services

15.3.4     Financial Overview

15.3.5     SWOT Analysis

15.3.6     Key Developments

15.4      BD

15.4.1     Key Facts

15.4.2     Business Description

15.4.3     Products and Services

15.4.4     Financial Overview

15.4.5     SWOT Analysis

15.4.6     Key Developments

15.5      Danaher (Beckman Coulter)

15.5.1     Key Facts

15.5.2     Business Description

15.5.3     Products and Services

15.5.4     Financial Overview

15.5.5     SWOT Analysis

15.5.6     Key Developments

15.6      Luminex Corporation

15.6.1     Key Facts

15.6.2     Business Description

15.6.3     Products and Services

15.6.4     Financial Overview

15.6.5     SWOT Analysis

15.6.6     Key Developments

15.7      THERMO FISHER SCIENTIFIC INC.

15.7.1     Key Facts

15.7.2     Business Description

15.7.3     Products and Services

15.7.4     Financial Overview

15.7.5     SWOT Analysis

15.7.6     Key Developments

15.8      bioMerieux SA

15.8.1     Key Facts

15.8.2     Business Description

15.8.3     Products and Services

15.8.4     Financial Overview

15.8.5     SWOT Analysis

15.8.6     Key Developments

15.9      T2 Biosystems, Inc.

15.9.1     Key Facts

15.9.2     Business Description

15.9.3     Products and Services

15.9.4     Financial Overview

15.9.5     SWOT Analysis

15.9.6     Key Developments

16.        Appendix

16.1      About the Insight Partners

16.2      Glossary of Terms

LIST OF TABLES

Table 1.             New next-generation sequencing techniques by Company

Table 2.             US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 3.             US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 4.             US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 5.             US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 6.             US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 7.             US: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 8.             US Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 9.             Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 10.          Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 11.          Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 12.          Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 13.          Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 14.          Canada: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 15.          Canada Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 16.          Mexico Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)

Table 17.          Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 18.          Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)

Table 19.          Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)

Table 20.          Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)

Table 21.          Mexico: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)

Table 22.          Mexico Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 23.          Recent Organic Growth Strategies in Sepsis Diagnostics Market

Table 24.          Inorganic Developments in the Sepsis Diagnostics Market

Table 25.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Sepsis Diagnostics Market Segmentation

Figure 2.           North America Sepsis Diagnostics Market, By Country

Figure 3.           North America Sepsis Diagnostics Market Overview

Figure 4.           Blood Culture Media Segment Held Largest Share of Type Segment in North America Sepsis Diagnostics Market

Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           North America Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints

Figure 9.           North America Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        North America Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)

Figure 11.        Instruments: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Reagents and Assays: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Blood Culture Media: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Software: North America Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        North America Sepsis Diagnostics Market Share by Technology - 2021 & 2028 (%)

Figure 16.        Molecular Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        Polymerase Chain Reaction: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18.        Peptide Nucleic Acid-Fluorescent in Situ Hybridization: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        Syndromic Panel-Based Testing: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        Microarrays: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        Flow Cytometry: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.        Real-Time Cell Analysis: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23.        Microfluidics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24.        Immunoassay: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25.        Biomarkers: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 26.        Metabolomics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 27.        Microbiology: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 28.        North America Sepsis Diagnostics Market Share by Method - 2021 & 2028 (%)

Figure 29.        Automated Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 30.        Conventional Diagnostics: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 31.        North America Sepsis Diagnostics Market Share by Test Type - 2021 & 2028 (%)

Figure 32.        Point-of-Care Tests: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 33.        Laboratory Tests: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 34.        North America Sepsis Diagnostics Market Share by Pathogen - 2021 & 2028 (%)

Figure 35.        Bacterial Sepsis: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 36.        Fungal Sepsis: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 37.        Others: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 38.        North America Sepsis Diagnostics Market Share by End User - 2021 & 2028 (%)

Figure 39.        Hospitals: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 40.        Pathology and Reference Laboratories: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 41.        Others: North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 42.        North America: North America Sepsis Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 43.        North America: North America Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 44.        US: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45.        Canada: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46.        Mexico: North America Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 47.          Growth Strategies in the Sepsis Diagnostics Market (%)